• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用茶碱治疗的早产儿的发育结局。

Developmental outcome of premature infants treated with theophylline.

作者信息

Nelson R M, Resnick M B, Holstrum W J, Eitzman D V

出版信息

Dev Pharmacol Ther. 1980;1(5):274-80.

PMID:7438973
Abstract

The methylated xanthines are known to have multiple metabolic effects. This study was performed to examine the development of premature infants treated with theophylline in the neonatal period for apnea. The theophylline-treated infants had lower Apgar scores and gestational ages when compared to those who did not receive theophylline. There were no significant differences in the developmental indices, and both groups had similar incidences of severe neurologic sequelae and retrolental fibroplasia. Similarly, there were no differences in the somatic growth. The data suggest that theophylline does not adversely affect development of premature infants when examined at 9--27 months of age.

摘要

已知甲基化黄嘌呤具有多种代谢作用。本研究旨在检查在新生儿期接受茶碱治疗以缓解呼吸暂停的早产儿的发育情况。与未接受茶碱治疗的婴儿相比,接受茶碱治疗的婴儿阿氏评分和胎龄较低。发育指标无显著差异,两组严重神经后遗症和晶状体后纤维增生的发生率相似。同样,身体生长方面也没有差异。数据表明,在9至27个月龄时检查,茶碱对早产儿的发育没有不利影响。

相似文献

1
Developmental outcome of premature infants treated with theophylline.用茶碱治疗的早产儿的发育结局。
Dev Pharmacol Ther. 1980;1(5):274-80.
2
[Hyponatremia and theophylline in very low birthweight premature infants].极低出生体重早产儿的低钠血症与茶碱
Arch Fr Pediatr. 1982 Aug-Sep;39(7):419-22.
3
[Preventive treatment with theophylline of apnea in premature infants: clinical, pharmokinetic and neurophysiological study].
Arch Fr Pediatr. 1978 Aug-Sep;35(7):793-805.
4
[Apnea and theophylline in the premature infant. Clinical and pharmacokinetic study in 32 premature infants].
Pediatrie. 1981 Mar;36(2):91-101.
5
Treatment of severe apnea in prematures with orally administered theophylline.
Pediatrics. 1975 May;55(5):595-8.
6
Factors affecting theophylline pharmacokinetics in premature infants with apnea.影响呼吸暂停早产儿茶碱药代动力学的因素。
Dev Pharmacol Ther. 1980;1(1):6-15.
7
[Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline].[用氨茶碱治疗早产儿呼吸暂停期间氨茶碱和咖啡因的治疗浓度]
Arch Fr Pediatr. 1985 Jun-Jul;42(6):465-9.
8
A randomized controlled trial of theophylline versus CO2 inhalation for treating apnea of prematurity.氨茶碱与吸入二氧化碳治疗早产儿呼吸暂停的随机对照试验
J Pediatr. 2008 Oct;153(4):513-8. doi: 10.1016/j.jpeds.2008.04.025. Epub 2008 Jun 4.
9
T4 levels in methylxanthine-treated premature newborns.甲基黄嘌呤治疗的早产新生儿的甲状腺素(T4)水平。
Pediatr Pharmacol (New York). 1983;3(3-4):267-72.
10
Theophylline affects sleep-wake state development in premature infants.茶碱影响早产儿睡眠-觉醒状态的发育。
Neuropediatrics. 1985 Feb;16(1):13-8. doi: 10.1055/s-2008-1052537.